Experimental immunotherapy for eye cancer improves survival in early trials – Tech Explorist (press release)
|
Experimental immunotherapy for eye cancer improves survival in early trials
Tech Explorist (press release) In a small trial of patients with advanced metastatic uveal melanoma, Columbia scientists performed an experimental immunotherapy IMCgp100 and found that it could increase their survival rate for one year. The immunotherapy is specially designed with … |
